Nano-X Imaging Ltd. (NASDAQ: NNOX) announced on September 8, 2026, that its U.S. subsidiary, Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp. to expand the deployment of the Nanox.ARC system across New England. The partnership is designed to market, distribute, and support the FDA-cleared, multisource 3D digital tomosynthesis system, leveraging Associated X-Ray Imaging's regional customer relationships and service infrastructure.
This agreement marks a strategic expansion of Nanox's U.S. channel partner network, with the goal of increasing access to the Nanox.ARC in outpatient and community-based clinical settings. By tapping into Associated X-Ray Imaging's established presence in the region, Nanox aims to accelerate the adoption of its imaging technology in non-hospital environments, potentially improving early detection and patient outcomes.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis system designed for ease of use and scalability. It is part of Nanox's broader ecosystem that includes AI-based solutions, cloud-based software, remote radiology services, and health IT solutions. The company's vision is to expand the reach of medical imaging beyond traditional hospital settings, providing a seamless solution from scan to interpretation.
According to the press release, the distribution agreement is intended to increase the availability of the Nanox.ARC in targeted markets, which could have significant implications for healthcare providers and patients in New England. By offering a more affordable and accessible imaging solution, Nanox aims to lower barriers to adoption and improve utilization of advanced imaging technologies.
Industry analysts note that such partnerships are crucial for medical device companies to penetrate regional markets effectively. Associated X-Ray Imaging's expertise in servicing imaging equipment will likely ensure that healthcare facilities receive proper support, which is essential for the successful implementation of new technology.
The expansion comes as Nanox continues to build its U.S. presence, following the FDA clearance of the Nanox.ARC. The company has been actively seeking distribution partners to broaden its reach. This latest agreement is expected to complement existing partnerships and help Nanox achieve its goal of driving the world's transition to preventive health care.
For more details on the full press release, interested parties can visit https://nnw.fm/ChGtd.
Nanox's integrated platform combines imaging hardware, AI, cloud infrastructure, and health IT to enhance clinical efficiency and broaden access to care. The company's focus on preventive health care is timely, as the healthcare industry increasingly emphasizes early detection and cost-effective solutions.
The announcement is part of Nanox's ongoing efforts to expand its footprint in the U.S. and globally. By strengthening its distribution network, Nanox is positioning itself to capture a larger share of the outpatient imaging market, which is growing due to the shift toward value-based care.
As with any forward-looking statements, the company cautions that actual results may differ due to risks and uncertainties. These factors are detailed in Nanox's filings with the Securities and Exchange Commission. The company undertakes no obligation to update this information unless required by law.
